Role of Pippali Rasayana in improving lung function in Chronic Obstructive Pulmonary Disease
Keywords:Pippali, Rasayana, COPD, PFT, Rejuvenation
ABSTRACT- Chronic Obstructive Pulmonary Disease (COPD) is a chronic, recurrence condition, prevalent in the general population. In modern medicine, treatment modalities are aimed to reduce the frequency and severity of exacerbations of the clinical features. now a day in ayurveda pippali rasayana being considered as a promising treatment approach for COPD. Due to methodological limitations, there is no strong evidence to support the pippali rasayana. methods: 60 Chronic Obstructive Pulmonary Disease patients (30 in each group) who met the inclusion criteria were chosen for the current study. Group A (Interventional group) received treatment with Pippali Rasayana (2.5 gm once a day in morning), whereas Group B (control group) received treatment with Cap Placebo (Starch powder) (250 mg once a day in morning). Both groups received the medicine prescribed by pulmonologist. Results:Both groups' subjective and objective parameters significantly improved throughout the course of treatment. However, the Interventional group showed superior improvement. Conclusion: The study offered solid support for the effectiveness and security of pipali rasayana when used as an adjuvant therapy along with modern medicine treatment is more effective in reducing the symptoms of COPD.
How to Cite
Copyright (c) 2022 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.